Correction: Establishment and Characterization of PCL12, a Novel CD5+ Chronic Lymphocytic Leukaemia Cell Line.

Table 1

“Detailed immunogenetic, genetic and cell phenotype information of the PCL12 cell line and comparison to the respective properties of the MEC1 and MEC2 cell lines,” is missing a column.

Please see the corrected Table 1 here.

		PCL12	MEC1	MEC2
Immunogenetics	IGH rearrangement	V3-30-3 | D2-15 | J6	V4-59 | D2-21 | J4
	IGHV mutation status	100%	94.65%
	VH CDR3	AREGALAGDIVVVVAANYYYYYGMDV	ARSQGVLTAIDY
	VH CDR3 length	26	12
	IGL rearrangement	Igλ (V2-8 | J2/3)	Igκ (V4-1 | J2)
Genetics	NOTCH1	no mutations	c.7544_7545delCT	-
	SF3B1	no mutations	no mutations	-
	TP53	R72 polymorphism	R72 polymorphism	-
		c.521C>G, p.P174T	c.949_950insC	-
	MYD88	no mutations	no mutations	-
	del17p13	no	yes	-
Cell markers	CD5	95%	0%	0%
	CD10	0%	0%	0%
	CD19	100%	99%	99%
	CD20	92%	96%	96%
	CD22	98%	76%	67%
	CD23	90%	89%	36%
	CD27	98%	99%	-
	CD38	78%	90%	99%
	CD45	97%	99%	92%
	CD80	35%	98%	91%
	CD83	40%	4%	-
	CD95	90%	90%	63%
	CD200	26%	0%	-
	IgD	54%	97%	99%
	IgM	50%	99%	94%
	HLA-DR	43%	99%	97%
	FMC7	0%	8%	72%
	ZAP70	37%	18%	-
	CXCR4	9%	5%	-
	CXCR5	42%	12%	-
	VLA4	90%	98%	-
	CD54	72%	98%	98%
	p-ERK	87%	Positive WB 28	-